DK1432731T3 - Diagnose og monitering af systemisk lupus erythematosus og af scleroderma - Google Patents

Diagnose og monitering af systemisk lupus erythematosus og af scleroderma

Info

Publication number
DK1432731T3
DK1432731T3 DK02757691.7T DK02757691T DK1432731T3 DK 1432731 T3 DK1432731 T3 DK 1432731T3 DK 02757691 T DK02757691 T DK 02757691T DK 1432731 T3 DK1432731 T3 DK 1432731T3
Authority
DK
Denmark
Prior art keywords
monitoring
scleroderma
diagnosis
lupus erythematosus
systemic lupus
Prior art date
Application number
DK02757691.7T
Other languages
English (en)
Inventor
Joseph M Ahearn
Susan M Manzi
Original Assignee
Univ Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pittsburgh filed Critical Univ Pittsburgh
Application granted granted Critical
Publication of DK1432731T3 publication Critical patent/DK1432731T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/104—Lupus erythematosus [SLE]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/967—Standards, controls, materials, e.g. validation studies, buffer systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/973—Simultaneous determination of more than one analyte
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/821—Chemistry: analytical and immunological testing involving complement factors or complement systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/101666—Particle count or volume standard or control [e.g., platelet count standards, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK02757691.7T 2001-09-10 2002-09-09 Diagnose og monitering af systemisk lupus erythematosus og af scleroderma DK1432731T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31854101P 2001-09-10 2001-09-10
PCT/US2002/028910 WO2003022223A2 (en) 2001-09-10 2002-09-09 Diagnosis and monitoring of systemic lupus erythematosus and of scleroderma

Publications (1)

Publication Number Publication Date
DK1432731T3 true DK1432731T3 (da) 2010-11-22

Family

ID=23238613

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02757691.7T DK1432731T3 (da) 2001-09-10 2002-09-09 Diagnose og monitering af systemisk lupus erythematosus og af scleroderma

Country Status (10)

Country Link
US (1) US7390631B2 (da)
EP (1) EP1432731B1 (da)
JP (2) JP4570872B2 (da)
AT (1) ATE479707T1 (da)
AU (2) AU2002323691C1 (da)
CA (1) CA2460189A1 (da)
DE (1) DE60237529D1 (da)
DK (1) DK1432731T3 (da)
ES (1) ES2350922T3 (da)
WO (1) WO2003022223A2 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002323691C1 (en) 2001-09-10 2009-03-05 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Diagnosis and monitoring of systemic lupus erythematosus and of scleroderma
AU2004232007B2 (en) * 2003-04-16 2009-10-22 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Identification and monitoring of systematic lupus erythematosus
ES2342291T3 (es) 2003-06-13 2010-07-05 University Of Pittsburgh Control de enfermedades inmunologicas, hematologicas e inflamatorias.
DE602005023009D1 (de) * 2004-04-09 2010-09-30 Univ Pittsburgh Verfahren in echtzeit zur erkennung von akuten entzündungszuständen
DK1745287T3 (da) * 2004-05-11 2011-01-24 Univ Pittsburgh Diagnostisering og monitorering af inflammatoriske sygdomme ved at måle komplementkomponenter på hvide blodlegemer
WO2007095154A2 (en) * 2006-02-10 2007-08-23 The Brigham And Women's Hospital, Inc. Lectin complement pathway assays and related compositions and methods
FR2899337B1 (fr) * 2006-03-31 2008-07-04 Univ Reims Champagne Ardenne Standard c4d / c4b pour cytometrie de flux quantitative du rejet humoral de transplantation.
AU2009305575A1 (en) * 2008-10-16 2010-04-22 Cypress Bioscience, Inc. Method for diagnosis and monitoring of disease activity and response to treatment in systemic lupus erythematosus (SLE) and other autoimmune diseases
RU2435524C1 (ru) * 2010-04-12 2011-12-10 Учреждение Российской академии медицинских наук Научный центр здоровья детей РАМН (НЦЗД РАМН) Способ диагностики системной красной волчанки и антифосфолипидного синдрома у детей
WO2012109592A1 (en) 2011-02-11 2012-08-16 Exagen Diagnostics, Inc. Methods for diagnosing systemic lupus erythematosus
US9863946B2 (en) 2013-02-08 2018-01-09 Allegheny-Singer Research Institute Cell-bound complement activation products as diagnostic biomarkers for pre-lupus
RU2680270C2 (ru) 2013-02-08 2019-02-19 Аллегени-Сингер Рисерч Инститьют Клеточно-связанные продукты активации комплемента в качестве диагностических биомаркеров волчанки в доклинической стадии
CN105229470B (zh) 2013-03-15 2018-11-27 艾克斯肯诊断股份有限公司 用于治疗和诊断系统性红斑狼疮的方法
US10067128B2 (en) 2015-07-31 2018-09-04 Allegheny-Singer Research Institute Cell-bound complement activation product assays as companion diagnostics for antibody-based drugs
AU2017269968B2 (en) 2016-05-24 2024-02-01 Allegheny-Singer Research Institute Methods and systems using C4 gene copy number and cell-bound complement activation products for identification of lupus and pre-lupus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5426029A (en) * 1986-03-31 1995-06-20 T Cell Diagnostics, Inc. Therapeutic and diagnostic methods using leukocyte surface antigens
JPH02293665A (ja) * 1989-05-09 1990-12-04 Fujirebio Inc 腎疾患の検査方法
JPH07509783A (ja) 1992-10-30 1995-10-26 ティー　セル　ダイアグノスティックス，インコーポレーテッド 試料中の全分子の測定及びそれに基づく方法
AU2002323691C1 (en) 2001-09-10 2009-03-05 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Diagnosis and monitoring of systemic lupus erythematosus and of scleroderma
ES2342291T3 (es) 2003-06-13 2010-07-05 University Of Pittsburgh Control de enfermedades inmunologicas, hematologicas e inflamatorias.

Also Published As

Publication number Publication date
DE60237529D1 (de) 2010-10-14
WO2003022223A3 (en) 2003-07-24
EP1432731A4 (en) 2005-03-16
JP2010014720A (ja) 2010-01-21
WO2003022223A2 (en) 2003-03-20
ATE479707T1 (de) 2010-09-15
US20050037441A1 (en) 2005-02-17
EP1432731B1 (en) 2010-09-01
AU2008202941A1 (en) 2008-07-24
AU2002323691C1 (en) 2009-03-05
ES2350922T3 (es) 2011-01-28
AU2002323691B2 (en) 2008-04-03
CA2460189A1 (en) 2003-03-20
JP4570872B2 (ja) 2010-10-27
EP1432731A2 (en) 2004-06-30
JP2005509146A (ja) 2005-04-07
US7390631B2 (en) 2008-06-24
JP4906898B2 (ja) 2012-03-28

Similar Documents

Publication Publication Date Title
DK1432731T3 (da) Diagnose og monitering af systemisk lupus erythematosus og af scleroderma
Santos et al. Road map for the clinical application of the basophil activation test in food allergy
Lucas et al. A novel whole blood capillary technic for measuring the prothrombin time
WO2003008933A3 (en) Test strip for a lateral flow assay
Epstein et al. Temporal stability of serum concentrations of cytokines and soluble receptors measured across two years in low-risk HIV-seronegative men
DK1766400T3 (da) Fremgangsmåde til at udföre fuldblodsanalyser
EP1318399A3 (en) Passive sample detection to initiate timing of an assay
EP2149792A3 (en) Sample analyzing method and sample analyzing device
DE602004030586D1 (de) Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis
ATE406578T1 (de) Candida-nachweis
DK1706024T3 (da) Integreret diagnostisk testsystem
EP1260178A3 (en) Technique for diagnosing attention deficit hyperactivity disorder
Cava et al. Biological variation of interleukin 6 (IL-6) and soluble interleukin 2 receptor (sIL2R) in serum of healthy individuals
WO2003016555A1 (en) Cell diagnosing method, and device and apparatus used for it
Kolaczinski et al. Comparison of the OptiMAL® rapid antigen test with field microscopy for the detection of Plasmodium vivax and P. falciparum: Considerations for the application of the rapid test in Afghanistan
CA2564492A1 (en) Diagnosing and monitoring inflammatory diseases by measuring complement components on white blood cells
WO2005023291A3 (en) Use of glp1-agonists in the treatment of patients with type i diabetes
WO2002012892A3 (en) Rapid multiple panel of biomarkers in laboratory blood tests for tia/stroke
WO2005085292A3 (fr) Procede de detection de la forme libre activable du psa et son utilisation pour le diagnostic des pathologies benignes de la prostate et de l'adenocarcinome de la prostate
Lenters-Westra et al. Understanding the use of sigma metrics in hemoglobin A1c analysis
Rush et al. Point‐of‐care testing as a tool for screening for diabetes and pre‐diabetes
Oral Anticoagulation Monitoring Study Group Prothrombin measurement using a patient self-testing system. Oral Anticoagulation Monitoring Study Group
RU2020127365A (ru) Способы, применения и комплекты для диагностики пародонтита
WO2004023094A3 (en) Electrochemical analytical apparatus and method of using the same
Schenk et al. Point-of-care creatinine testing in children at risk for sudden deterioration of renal function.